Equol is neuroprotective during focal cerebral ischemia and reperfusion that involves p-Src and gp91phox

Current Neurovascular Research

Volumn 11, Issue 4, 2014, Pages 367-377

  Yu, Wei ^a,b   Wang, Yan ^a   Zhou, Dang Xia ^a   Zhao, Li Mei ^a   Li, Gui Rong ^c   Deng, Xiu Ling ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Equol; Focal cerebral ischemia reperfusion; Gp91phox; Neuroprotection; Src

Indexed keywords

EQUOL; LACTATE DEHYDROGENASE; MALONALDEHYDE; PROTEIN TYROSINE KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SMALL INTERFERING RNA; CYBB PROTEIN, RAT; GLUCOSE; MEMBRANE PROTEIN; NEUROPROTECTIVE AGENT; PROTEIN KINASE P60; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; GENE SILENCING; HISTOPATHOLOGY; HYPOXIA; MALE; MORTALITY; NEUROPROTECTION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PHEOCHROMOCYTOMA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANOXIA; BRAIN INFARCTION; COMPLICATION; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; METABOLISM; NERVOUS SYSTEM DISEASES; PC12 CELL LINE; PHOSPHORYLATION; REPERFUSION; SPRAGUE DAWLEY RAT;

ANIMALS; ANOXIA; BRAIN INFARCTION; DISEASE MODELS, ANIMAL; EQUOL; GENE EXPRESSION REGULATION; GLUCOSE; INFARCTION, MIDDLE CEREBRAL ARTERY; L-LACTATE DEHYDROGENASE; MALE; MALONDIALDEHYDE; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; PC12 CELLS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION;

EID: 84925747807     PISSN: 15672026     EISSN: 18755739     Source Type: Journal    
DOI: 10.2174/1567202611666140908094517     Document Type: Article

References (45)

1. Liu M, Wu B, Wang WZ, et al. Stroke in China: Epidemiology, prevention, and management strategies. Lancet Neurol 2007; 6(5): 456-64
2. Alexandrov AV. Current and future recanalization strategies for acute ischemic stroke. J Intern Med 2010; 267(2): 209-219
3. Warach S, Latour LL. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke 2004; 35(11 Suppl 1): 2659-2661
4. Infanger DW, Sharma RV, Davisson RL. NADPH oxidases of the brain: distribution, regulation, and function. Antioxid Redox Signal 2006; 8(9-10): 1583-1596
5. Sorce S, Krause KH. NOX enzymes in the central nervous system: From signaling to disease. Antioxid Redox Signal 2009; 11(10): 2481-2504
6. Kahles T, Brandes RP. Which NADPH oxidase isoform is relevant for ischemic stroke? The case for Nox2. Antioxid Redox Signal 2013; 18(12): 1400-1417
7. Shen J, Bai XY, Qin Y, et al. Interrupted reperfusion reduces the activation of NADPH oxidase after cerebral I/R injury. Free Radic Biol Med 2011; 50(12):1780-1786
8. Tang LL, Ye K, Yang XF, et al. Apocynin attenuates cerebral infarction after transient focal ischemia in rats. J Int Med Res 2007; 35(4): 517-522
9. Chen H, Song YS, Chan PH. Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion. J Cereb Blood Flow Metab. 2009; 29(7): 1262-1272
10. Kahles T, Luedike P, Endres M, et al. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 2007; 38(11): 3000-3006
11. Tang XN, Cairns B, Kim JY, et al. NADPH oxidase in stroke and cerebrovascular disease. Neurol Res. 2012; 34(4): 338-345
12. Mishra OP, Ashraf QM, Delivoria-Papadopoulos M. NO-mediated activation of Src kinase during hypoxia in the cerebral cortex of newborn piglets. Neurosci Lett 2009; 460(1): 61-65
13. Paul R, Zhang ZG, Eliceiri BP, et al. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat Med 2001; 7(2): 222-227
14. Lennmyr F, Ericsson A, Gerwins P, et al. Src family kinaseinhibitor PP2 reduces focal ischemic brain injury. Acta Neurol Scand 2004; 110(3): 175-179
15. Liang S, Pong K, Gonzales C, et al. Neuroprotective profile of novel Src kinase inhibitors in rodent models of cerebral ischemia. J Pharmacol Exp Ther 2009; 331(3): 827-835
16. Birt DF, Hendrich S, Wang W. Dietary agents in cancer prevention: Flavonoids and isoflavonoids. Pharmacol Ther 2001; 90(2-3): 157-177
17. Atkinson C, Frankenfeld CL, Lampe JW. Gut bacterial metabolism of the soy isoflavone daidzein: Exploring the relevance to human health. Exp Biol Med (Maywood) 2005; 230(3): 155-170
18. Morito K, Hirose T, Kinjo J, et al. Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull 2001; 24(4): 351-356
19. Mitchell JH, Gardner PT, McPhail DB, et al. Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch Biochem Biophys 1998; 360(1): 142-148
20. Rimbach G, De Pascual-Teresa S, Ewins BA, et al. Antioxidant and free radical scavenging activity of isoflavone metabolites. Xenobiotica 2003; 33(9): 913-925
21. Rüfer CE, Kulling SE. Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. J Agric Food Chem 2006; 54(8): 2926-2931
22. Turner R, Baron T, Wolffram S, et al. Effect of circulating forms of soy isoflavones on the oxidation of low density lipoprotein. Free Radical Res 2004; 38(2): 209-216
23. Cheng C, Wang X, Weakley SM, et al. The soybean isoflavonoid equol blocks ritonavir-induced endothelial dysfunction in porcine pulmonary arteries and human pulmonary artery endothelial cells. J Nutr 2010; 140(1): 12-17
24. Choi EJ, Kim GH. Anticancer mechanism of equol in 7, 12- dimethylbenz(a)anthracene-treated animals. Int J Oncol 2011; 39(3): 747-754
25. Schreihofer DA, Do DK, Schreihofer AM. High-soy diet decreases infarct size after permanent middle cerebral artery occlusion in female rats, Am J Physiol Regul Integr Comp Physiol 2005; 289(1): R103-R108
26. Ma Y, Sullivan JC, Schreihofer DA. Dietary genistein and equol (4', 7 isoflavandiol) reduce oxidative stress and protect rats against focal cerebral ischemia. Am J Physiol Regul Integr Comp Physiol 2010; 299(3): R871-R877
27. Wang Y, Zhang HT, Su XL, et al. Experimental diabetes mellitus down-regulates large-conductance Ca2+-activated K+ channels in cerebral artery smooth muscle and alters functional conductance. Curr Neurovasc Res 2010; 7(2): 75-84
28. Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20(1): 84-91
29. Wang Y, Deng XL, Xiao XH, et al. A non-steroidal antiinflammatory agent provides significant protection during focal ischemic stroke with decreased expression of matrix metalloproteinases. Curr Neurovasc Res 2007; 4(3): 176-183
30. Hu Q, Chen C, Yan J, et al. Therapeutic application of gene silencing MMP-9 in a middle cerebral artery occlusion-induced focal ischemia rat model. Exp Neurol 2009; 216(1): 35-46
31. Ca3.1 channels mediate the increase of cell migration and proliferation by advanced glycation end products in cultured rat vascular smooth muscle cells. Lab Invest 2013; 93(2): 159-167
32. Wang LP, Wang Y, Zhao LM, et al. Angiotensin II upregulates KCa3.1 channels and stimulates cell proliferation in rat cardiac fibroblasts. Biochem Pharmcol 2013; 85(10): 1486-1494
33. Koo BS, Lee WC, Chung KH, Ko JH, Kim CH. A water extract of Curcuma longa L. (Zingiberaceae) rescues PC12 cell death caused by pyrogallol or hypoxia/reoxygenation and attenuates hydrogen peroxide induced injury in PC12 cells. Life Sci 2004; 75(19): 2363-2375
34. Deng XL, Lau CP, Lai K, et al. Cell cycle-dependent expression of potassium channels and cell proliferation in rat mesenchymal stem cells from bone marrow. Cell Prolif 2007; 40(5): 656-670
35. Zhao LM, Zhang W, Wang LP, et al. Advanced glycation end products promote proliferation of cardiac fibroblasts by upregulation of KCa3.1 channels. Pflugers Arch 2012; 464(6): 613-621
36. Wu HW, Li HF, Wu XY, et al. Reactive oxygen species mediate ERK activation through different Raf-1-dependent signaling pathways following cerebral ischemia. Neurosci Lett. 2008; 432(2): 83-87
37. Lampe JW, Skor HE, Li S, et al. Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women. J Nutr 2001; 131(3): 740-744
38. Rowland IR, Wisemen H, Sanders TA, et al. Interindividual variation in metabolism of soy isoflavones and lignans: Influence of habitual diet on equol production by the gut microflora. Nutr Cancer 2000; 36(1): 27-32
39. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol-A clue to the effectiveness of soy and its isoflavones. J Nutr 2002; 132(12): 3577-3584
40. Duncan AM, Merz-Demlow BE, Xu X, et al. Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2000; 9(6): 581-586
41. Adibhatla RM, Hatcher JF. Lipid oxidation and peroxidation in CNS health and disease: From molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2010; 12(1): 125-169
42. Richardson TE, Simpkins JW. R- and S-equol have equivalent cytoprotective effects in Friedreich's ataxia. BMC Pharmacol Toxicol 2012; 13: 12
43. Hwang J, Wang J, Morazzoni P, et al. The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: An antioxidant mechanism for cell-mediated LDL modification. Free Radic Biol Med 2003; 34(10): 1271-1282
44. Bokoch GM, Diebold B, Kim JS, et al. Emerging evidence for the importance of phosphorylation in the regulation of NADPH oxidases. Antioxid Redox Signal 2009;11(10):2429-2441
45. Touyz RM, Yao G, Schiffrin EL. c-Src induces phosphorylation and translocation of p47phox role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003; 23(6): 981-987.